The Prospect of Lactoferrin Use as Adjunctive Agent in Management of SARS-CoV-2 Patients: A Randomized Pilot Study
Fahad Dhafer Algahtani, Mohamed Tharwat Elabbasy, Mai A Samak, Adeniyi A Adeboye, Rafeek A Yusuf, Mohamed E Ghoniem
Medicina, doi:10.3390/medicina57080842
Background and Objectives: Preventive, adjunctive and curative properties of lactoferrin have been evaluated since the first wave of severe acute respiratory syndrome coronavirus (SARS-CoV), a viral respiratory disease, emerged 18 years ago. Despite the discovery of new vaccine candidates, there is currently no widely approved treatment for SARS-CoV-2 (COVID-19). Strict adherence to infection prevention and control procedures, as well as vaccines, can, however, prevent the spread of SARS-CoV-2. This study aimed to evaluate the efficacy of lactoferrin treatment in improving clinical symptoms and laboratory indices among individuals with mild to moderate coronavirus disease-19 (COVID-19). Materials and Method: A randomized, prospective, interventional pilot study conducted between 8 July and 18 September 2020 used a hospital-based sample of 54 laboratoryconfirmed participants with mild to moderate symptoms of COVID-19. Randomization into a control and two treatment groups ensured all groups received the approved Egyptian COVID-19 management protocol; only treatment group participants received lactoferrin at different doses for seven days. Clinical symptoms and laboratory indices were assessed on Days 0, 2 and 7 after starting treatments. Mean values with standard deviation and one-way analysis of variance with least significant difference of demographic and laboratory data between control and treatment groups were calculated. Results: Our study showed no statistically significant difference among studied groups regarding recovery of symptoms or laboratory improvement. Conclusions: Further research into therapeutic properties particularly related to dosage, duration and follow-up after treatment with lactoferrin in individuals with COVID-19 is required.
Conflicts of Interest: The authors declare that they have no conflict of interest.
Abbreviations SARS-CoV-2: severe acute respiratory syndrome coronavirus-2; COVID-19: Coronavirus disease; Lf: Lactoferrin; Fe: Iron; WHO: World Health Organization; RT-PCR: reverse transcriptase polymerase chain reaction; LDH: Lactate dehydrogenase; ACE2: Angiotensin-converting enzyme 2; HSPGs: Heparan sulfate proteoglycans; IL: Interleukin; TNF alpha: Tumor Necrosis Factor alpha; CRP: C-reactive protein.
References
Angeletti, Benvenuto, Bianchi, Giovanetti, Pascarella et al., COVID-2019: The role of the nsp2 and nsp3 in its pathogenesis, J. Med. Virol,
doi:10.1002/jmv.25719Anurag, Jha, Kumar, Differential white blood cell count in the COVID-19: A cross-sectional study of 148 patients, Diabetes Metab. Syndr. Clin. Res. Rev,
doi:10.1016/j.dsx.2020.10.029Azhar, Mohammadabadi, Babar, Hussain, Milk lactoferrin: A probable immunological agent against sars-cov-2: A review, Basrah J. Agric. Sci,
doi:10.37077/25200860.2020.33.2.12Bajwa, Riaz, Ammar, Farooq, Yousaf, The Dilemma of Renal Involvement in COVID-19: A Systematic Review, Cureus,
doi:10.7759/cureus.8632Bertolini, Van De, Peppel, Bodewes, Moshage et al., Abnormal Liver Function Tests in Patients with COVID-19: Relevance and Potential Pathogenesis, Hepatology,
doi:10.1002/hep.31480Buey, Bellés, Latorre, Abad, Pérez et al., Comparative effect of bovine buttermilk, whey, and lactoferrin on the innate immunity receptors and oxidative status of intestinal epithelial cells, Biochem. Cell Biol
Campione, Lanna, Cosio, Rosa, Conte et al., Lactoferrin as Potential Supplementary Nutraceutical Agent in COVID-19 Patients: In vitro and in vivo Preliminary Evidences, BioRxiv,
doi:10.1101/2020.08.11.244996Cavezzi, Troiani, Corrao, COVID-19: Hemoglobin, Iron, and Hypoxia beyond Inflammation. A Narrative Review, Clin. Pract,
doi:10.4081/cp.2020.1271Cheng, Li, Li, Liu, Yan et al., Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis, J. Clin. Lab. Anal,
doi:10.1002/jcla.23618Costagliola, Spada, Comberiati, Peroni, Could nutritional supplements act as therapeutic adjuvants in COVID-19?, Ital. J. Pediatr,
doi:10.1186/s13052-021-00990-0Cutone, Ianiro, Lepanto, Rosa, Valenti et al., Lactoferrin in the Prevention and Treatment of Intestinal Inflammatory Pathologies Associated with Colorectal Cancer Development, Cancers,
doi:10.3390/cancers12123806Dhama, Sharun, Tiwari, Sircar, Bhat et al., Coronavirus Disease 2019-COVID-19, Clin. Microbiol. Rev,
doi:10.1128/CMR.00028-20El-Khawaga, Abdelmaksoud, Effect of Lactoferrin Supplementation on Iron Deficiency Anemia in Primary School Children, Int. J. Med. Arts,
doi:10.21608/ijma.2019.12596.1003Elmenam, Farouk, Bovine lactoferrin in preterm labor with sterile inflammation, Sci. J. Al-Azhar Med. Fac. Girls
Farid, El Shemy, Nafie, Hegazy, Abdelhiee, Anti-inflammatory, anti-oxidant and hepatoprotective effects of lactoferrin in rats, Drug Chem. Toxicol,
doi:10.1080/01480545.2019.1585868Feng, Fei, Xia, Labropoulou, Swevers et al., Antimicrobial Peptides as Potential Antiviral Factors in Insect Antiviral Immune Response, Front. Immunol,
doi:10.3389/fimmu.2020.02030Henry, Aggarwal, Wong, Benoit, Vikse et al., Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis, Am. J. Emerg. Med,
doi:10.1016/j.ajem.2020.05.073Hsu, Chiu, Lin, Chen, Lee et al., Lactoferrin Contributes a Renoprotective Effect in Acute Kidney Injury and Early Renal Fibrosis, Pharmaceutics,
doi:10.3390/pharmaceutics12050434Hu, Meng, Zhang, Xiang, Wang, The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor, Emerg. Microbes Infect,
doi:10.1080/22221751.2021.1888660Kell, Heyden, Pretorius, The biology of lactoferrin, an iron-binding protein that can help de-fend against viruses and bacteria, Front. Immunol,
doi:10.3389/fimmu.2020.01221Khajeh, Jamshidian-Mojaver, Naeemipour, Farzin, The Identification of a Novel Peptide Derived from Lactoferrin Isolated from Camel Milk with Potential Antimicrobial Activity, Iran. J. Med. Microbiol
Kruzel, Olszewska, Pazdrak, Krupinska, Actor, New insights into the systemic effects of oral lactoferrin: Transcriptome profiling, Biochem. Cell Biol,
doi:10.1139/bcb-2020-0069Lodhi, Aslam, Sajid, Zulfiqar, Lactoferrin as Nutraceutical Protein from Milk, J. Nutraceuticals Food Sci
Padrão, Ribeiro, Lanceros-Méndez, Rodrigues, Dourado, Effect of bacterial nanocellulose binding on the bactericidal activity of bovine lactoferrin, Heliyon,
doi:10.1016/j.heliyon.2020.e04372Peroni, Viral infections: Lactoferrin, a further arrow in the quiver of prevention, J. Pediat. Neonatal Individ. Med. (JPNIM
Quintieri, Caputo, Monaci, Cavalluzzi, Denora, Lactoferrin-derived peptides as a con-trol strategy against skinborne staphylococcal biofilms, Biomedicines,
doi:10.3390/biomedicines8090323Salaris, Scarpa, Elli, Bertolini, Guglielmetti et al., Protective effects of lactoferrin against SARS-CoV-2 infection in vitro, Nutrients,
doi:10.3390/nu13020328Serrano, Kochergina, Albors, Diaz, Oroval et al., Liposomal Lactoferrin as Potential Preventative and Cure for COVID-19, Int. J. Res. Health Sci,
doi:10.5530/ijrhs.8.1.3Shahidi, Roshanak, Javadmanesh, Yazdi, Pirkhezranian et al., Evaluation of antimicrobial properties of bovine lactoferrin against foodborne pathogenic microorganisms in planktonic and bio-film forms (in vitro), J. Consum. Prot. Food Saf,
doi:10.1007/s00003-020-01280-3Sienkiewicz, Jaśkiewicz, Tarasiuk, Fichna, Lactoferrin: An overview of its main functions, immunomodulatory and antimicrobial role, and clinical significance, Crit. Rev. Food Sci. Nutr,
doi:10.1080/10408398.2021.1895063Wang, Wang, Wang, Luo, Wan et al., Lactoferrin for the treatment of COVID-19, Exp. Ther. Med
Wang, Wu, Zhang, Wu, Yu et al., C-Reactive Protein Level May Predict the Risk of COVID-19 Aggravation, Open Forum Infect. Dis,
doi:10.1093/ofid/ofaa153Wool, Miller, The Impact of COVID-19 Disease on Platelets and Coagulation, Pathobiology,
doi:10.1159/000512007Xu, Dong, An, Lv, Yin et al., Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2, J. Infect
Yang, Cao, Gao, Wu, Wang et al., Discovery, optimization, and target identi-fication of novel potent broad-spectrum antiviral inhibitors, J. Med. Chem,
doi:10.1021/acs.jmedchem.9b00091Zhavoronkov, Aladinskiy, Zhebrak, Zagribelnyy, Terentiev et al., Potential COVID-2019 3C-Like Protease Inhibitors Designed Using Generative Deep Learning Approaches
